Original articleGeneral thoracicDoes Bilobectomy Offer Satisfactory Long-Term Survival Outcome for Non-Small Cell Lung Cancer?
Section snippets
Data Collection
Retrospective analysis was performed on patients with non-small cell lung cancer having undergone bilobectomy from January 1999 to June 2012 at our institution (Department of Thoracic Surgery, University Hospital of Caen, France). Institutional Review Board approval was obtained to perform this retrospective investigation. The following were recorded: age, gender, American Society of Anesthesiologists score, body mass index (in kg/m²), forced expiratory volume in 1 second (FEV1), type of
Patient Characteristics
Bilobectomies were performed on 85 male and 18 female patients, of a mean age of 61.9 years (range 43 to 82 years). Comorbidity factors are listed in Table 1. Surgical indications are presented in Table 2. Fifty-four upper-middle bilobectomies (including 2 sleeve resections) and 49 lower-middle bilobectomies were performed. Neoadjuvant chemotherapy was performed in 26 patients. Twenty-five patients had COPD. A total of 74 bronchial stumps were closed automatically by staples and 29 manually by
Comment
After the first bilobectomy performed by Churchill in 1933 [12], the first series were not published until the 1990s 4, 5. Since then, the postoperative course of this resection has generally been considered as intermediate between lobectomy and pneumonectomy.
References (20)
- et al.
Bilobectomy for bronchogenic carcinoma
Ann Thorac Surg
(1988) - et al.
Are bilobectomies acceptable procedures?
Ann Thorac Surg
(1995) - et al.
Bilobectomy for non-small cell lung cancer: a search for clinical factors that may affect perioperative morbidity and long-term survival
J Thorac Cardiovasc Surg
(2010) - et al.
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours
J Thorac Oncol
(2007) - et al.
Utility of C-reactive protein measurements for empyema diagnosis after pneumonectomy
Ann Thorac Surg
(1994) The surgical treatment of carcinoma of the lung
J Thorac Surg
(1933)- et al.
Data from the Society Of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors
J Thorac Cardiovasc Surg
(2008) The incidence, etiology, and prevention of postresectional bronchopleural fistula
Semin Thorac Cardiovasc Surg
(2001)- et al.
Impact of induction treatment on postoperative complications in the treatment of non-small cell lung cancer
J Thorac Oncol
(2007) - et al.
Morbidity and mortality of major pulmonary resection in patients with early-stage lung cancer: initial results of the randomized prospective ACOSOG Z0030 trial
Ann Thorac Surg
(2006)
Cited by (8)
Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non–small cell lung cancer in the randomized phase III IMpower010 trial
2023, Journal of Thoracic and Cardiovascular SurgeryBilobectomy Versus Lobectomy for Non-Small Cell Lung Cancer: A Comparative Study of Outcomes, Long-Term Survival, and Quality of Life
2015, Annals of Thoracic SurgeryCitation Excerpt :In the current analysis, we found that no survival differences were observed when comparing types of bilobectomy (MLG versus UMG). That is similar to the report of Icard and colleagues [5]. Although the present study was specifically designed to minimize selection bias of confounders through propensity score-matched analysis, several potential limitations remain.
Invited Commentary
2015, Annals of Thoracic SurgeryLong-term prognosis of patients with non-small cell lung cancer after bilobectomy and the associated risk factors
2017, International Journal of Clinical and Experimental MedicineDoes tumor volume affect survival in patients with operated early-stage non-small-cell lung cancer?
2017, Turkish Journal of Thoracic and Cardiovascular Surgery